Freeline therapeutics holdings plc
Biotechnology:-Biological-Products-(No-Diagnostic-Substances)
FRLN
Stevenage Bioscience Catalyst
Stevenage , SG1 2FX
Stevenage , SG1 2FX
Executive/
Director
Links
Price
- Last Close
-
$ 0.25
$ +0 1.22 %
May 11, 2023
- 52-Week High/Low
- $0 - $0
- YTD
- 0%
- Trading Volume
- 328,523
- Market Cap Full
- $ 16.3M
- Shares Outstanding
-
65.1M
Dec 31, 2022
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | - | -5% | -32.6% | -43.4% | -7.6% | - |
| Q2 | - | - | - | - | - | 4% | -33.7% | -22.3% | -46.1% | - |
| Q3 | - | - | - | - | - | 8% | -58.2% | -19.5% | - | - |
| Q4 | - | - | - | - | - | 14.8% | -41.9% | -28.9% | - | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | 17.9% | -12.8% | -10.2% | -26.5% | -26.6% | - | - | - | - | - | - | - |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | -89% | -75% | -50% | 0% |
Earnings
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Q1 | - | -0.98 | -0.63 | 0.02 |
| Q2 | - | - | - | -0.21 |
| Q3 | - | - | - | -0.18 |
| Q4 | - | - | -5.22 | - |
| A | -6.8 | -3.9 | -1.5 | -0.37 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Mar | - | - | - |
| Jun | - | - | - |
| Sep | - | - | - |
| Dec | 35.9 | 35.9 | 65.1 |
Annual
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Asset Management | |||||
| Inventory / Stock Turnover | - | - | - | - | - |
| Fixed Asset Turnover | - | - | - | - | - |
| Total Asset Turnover | - | - | - | - | - |
| Leverage | |||||
| Debt Ratio | - | - | - | - | - |
| Debt – Equity Ratio | - | - | - | - | - |
| Interest Coverage | 10.9 | 71 | 17 | 6.4 | - |
| Equity multiplier | 0.3 | 0.1 | - | 0.1 | - |